Salicylic Acid

Manufacturer
Harmon Store Inc
Effective date
2024-01-29
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
legacy-cache
Hydrated at
2026-08-01 21:12:14

Label at a glance#

ProductSalicylic Acid
Active ingredientSALICYLIC ACID
Label structure9 sections

Indications and uses

for the removal of common and plantar warts. The common wart is easily recognized by the rough 'cauliflower-like' appearance of the surface. Plantar wart is recognized by the location only on the bottom of the foot, its tenderness and the interruption of the footprint pattern.

Dosage and administration

wash affected area, may soak wart in warm water for 5 minutes dry area thoroughly apply small amount of wart remover with applicator to sufficiently cover each wart let dry and repeat this procedure once or twice daily until wart is removed for up to 12 weeks

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 17%w/w

Purpose

OTC - PURPOSE SECTION

Wart Remover

Uses

INDICATIONS & USAGE SECTION

  • for the removal of common and plantar warts. The common wart is easily recognized by the rough 'cauliflower-like' appearance of the surface. Plantar wart is recognized by the location only on the bottom of the foot, its tenderness and the interruption of the footprint pattern.

Warnings

WARNINGS SECTION

For external use only.

Flammable

SAFE HANDLING WARNING SECTION

  • keep away from fire or flame
  • cap bottle tightly and store at room temerature away from heat

Do not use

OTC - DO NOT USE SECTION

  • if you are a diabetic or have poor blood circulation, except under the advice and supervision of a doctor or podiatrist
  • on genital warts and warts on the face
  • on moles, birthmarks and warts with hair growing from them
  • on mucous membranes
  • on irritated, infected or reddened skin

When using this product

OTC - WHEN USING SECTION

  • avoid contact with eyes. If product gets into the eyes, flush with water for 15 minutes
  • avoid inhaling vapors

Stop use and ask doctor if

OTC - STOP USE SECTION

discomfort persists.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

if swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • wash affected area, may soak wart in warm water for 5 minutes
  • dry area thoroughly
  • apply small amount of wart remover with applicator to sufficiently cover each wart
  • let dry and repeat this procedure once or twice daily until wart is removed for up to 12 weeks

Other information

OTHER SAFETY INFORMATION

store between 20° to 30°C (68° to 86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

camphor, castor oil, ethanol, ethyl ether, nitrocellulose

Questions?

OTC - QUESTIONS SECTION

Call 1-866-964-0939

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Harmon FaceValues

MAXIMUM STRENGTH

Wart Remover

Salicylic Acid

Liquid Treatment

  • Removes Common & Plantar Wart
  • Convenient Applicator
  • Safe and Effective Wart Removal

NET WT 0.31 FL OZ (9mL)

HAR Liq Wart Remover BOX.jpgHAR Liq Wart Remover BOX.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63940-01963940-019-31

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1adc29d6-9e19-7504-e063-6394a90aed533bc19775-79e8-45be-b0df-a353bb1e2f7d2024-06-14WarningsExact identifier
spl set id: 3bc19775-79e8-45be-b0df-a353bb1e2f7d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.